Kobayashi Pharmaceutical Co Financial Overview
Kobayashi Pharmaceutical Co's market cap is currently ¥390.10B. The company's EPS TTM is ¥48.99; its P/E ratio is 33.91; and it has a dividend yield of 1.96%. Kobayashi Pharmaceutical Co is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
